Page last updated: 2024-09-03

gefitinib and Sepsis

gefitinib has been researched along with Sepsis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baig, MS; Banerjee, S; Kizil, B; Muthu, K; Saqib, U; Srivastava, M; Wary, K	1

Other Studies

1 other study(ies) available for gefitinib and Sepsis

Article	Year
Inhibition of the TIRAP-c-Jun interaction as a therapeutic strategy for AP1-mediated inflammatory responses. International immunopharmacology, 2019, Volume: 71 Topics: Animals; Cells, Cultured; Disease Models, Animal; Gefitinib; Humans; Inflammation; Lipopolysaccharides; Macrophages; Male; Membrane Glycoproteins; Mice; Molecular Docking Simulation; Molecular Targeted Therapy; Protein Binding; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-jun; Receptors, Interleukin-1; Sepsis; Signal Transduction; Toll-Like Receptor 4; Transcription Factor AP-1	2019

Article

Year

Inhibition of the TIRAP-c-Jun interaction as a therapeutic strategy for AP1-mediated inflammatory responses.

International immunopharmacology, 2019, Volume: 71

Topics: Animals; Cells, Cultured; Disease Models, Animal; Gefitinib; Humans; Inflammation; Lipopolysaccharides; Macrophages; Male; Membrane Glycoproteins; Mice; Molecular Docking Simulation; Molecular Targeted Therapy; Protein Binding; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-jun; Receptors, Interleukin-1; Sepsis; Signal Transduction; Toll-Like Receptor 4; Transcription Factor AP-1

2019